Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
 Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2020   98,035,829      
Beginning balance at Dec. 31, 2020 $ 25,289,114 $ 98,036 $ 161,541,448 $ (136,350,370)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,147,268)     (2,147,268)  
Stock-based compensation 394,870   394,870    
Stock issued for vested restricted stock awards (in shares)   1,467,465      
Stock issued for vested restricted stock awards 0 $ 1,467 (1,467)    
Shares withheld for taxes on vested restricted stock (161,244)   (161,244)    
Proceeds from exercise of options 1,569   1,569    
Sale of common stock, net (in shares)   19,015,151      
Sale of common stock, net 13,137,500 $ 19,016 13,118,484    
Ending balance (in shares) at Mar. 31, 2021   118,518,445      
Ending balance at Mar. 31, 2021 36,514,541 $ 118,519 174,893,660 (138,497,638)  
Beginning balance (in shares) at Dec. 31, 2020   98,035,829      
Beginning balance at Dec. 31, 2020 25,289,114 $ 98,036 161,541,448 (136,350,370)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,359,663)        
Unrealized gain (loss) on debt securities 0        
Ending balance (in shares) at Sep. 30, 2021   118,747,447      
Ending balance at Sep. 30, 2021 33,369,062 $ 118,748 175,960,347 (142,710,033)  
Beginning balance (in shares) at Mar. 31, 2021   118,518,445      
Beginning balance at Mar. 31, 2021 36,514,541 $ 118,519 174,893,660 (138,497,638)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,382,127)     (2,382,127)  
Stock-based compensation 557,602   557,602    
Ending balance (in shares) at Jun. 30, 2021   118,518,445      
Ending balance at Jun. 30, 2021 34,690,016 $ 118,519 175,451,262 (140,879,765)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,830,268)     (1,830,268)  
Unrealized gain (loss) on debt securities 0        
Stock-based compensation 613,544   613,544    
Stock issued for vested restricted stock awards (in shares)   229,002      
Stock issued for vested restricted stock awards 0 $ 229 (229)    
Shares withheld for taxes on vested restricted stock (110,805)   (110,805)    
Stock warrants issued for referral agreement 6,575   6,575    
Ending balance (in shares) at Sep. 30, 2021   118,747,447      
Ending balance at Sep. 30, 2021 33,369,062 $ 118,748 175,960,347 (142,710,033)  
Beginning balance (in shares) at Dec. 31, 2021   118,747,447      
Beginning balance at Dec. 31, 2021 32,807,995 $ 118,748 176,586,529 (143,951,019) $ 53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,089,263)     (2,089,263)  
Unrealized gain (loss) on debt securities (98,156)       (98,156)
Stock-based compensation 671,158   671,158    
Stock issued for vested restricted stock awards (in shares)   1,059,755      
Stock issued for vested restricted stock awards 0 $ 1,060 (1,060)    
Shares withheld for taxes on vested restricted stock (128,520)   (128,520)    
Stock warrants issued for referral agreement 12,483   12,483    
Ending balance (in shares) at Mar. 31, 2022   119,807,202      
Ending balance at Mar. 31, 2022 31,175,697 $ 119,808 177,140,590 (146,040,282) (44,419)
Beginning balance (in shares) at Dec. 31, 2021   118,747,447      
Beginning balance at Dec. 31, 2021 32,807,995 $ 118,748 176,586,529 (143,951,019) 53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (9,129,756)        
Unrealized gain (loss) on debt securities (186,239)        
Ending balance (in shares) at Sep. 30, 2022   120,137,124      
Ending balance at Sep. 30, 2022 25,214,581 $ 120,138 178,307,716 (153,080,771) (132,502)
Beginning balance (in shares) at Mar. 31, 2022   119,807,202      
Beginning balance at Mar. 31, 2022 31,175,697 $ 119,808 177,140,590 (146,040,282) (44,419)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,229,927)     (3,229,927)  
Unrealized gain (loss) on debt securities (124,253)       (124,253)
Stock-based compensation 684,376   684,376    
Stock issued for vested restricted stock awards (in shares)   66,666      
Stock issued for vested restricted stock awards 0 $ 66 (66)    
Stock warrants issued for referral agreement 462   462    
Ending balance (in shares) at Jun. 30, 2022   119,873,868      
Ending balance at Jun. 30, 2022 28,506,355 $ 119,874 177,825,362 (149,270,209) (168,672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,810,562)     (3,810,562)  
Unrealized gain (loss) on debt securities 36,170       36,170
Stock-based compensation 535,458   535,458    
Stock issued for vested restricted stock awards (in shares)   263,256      
Stock issued for vested restricted stock awards 0 $ 264 (264)    
Shares withheld for taxes on vested restricted stock (68,372)   (68,372)    
Stock warrants issued for referral agreement 15,532   15,532    
Ending balance (in shares) at Sep. 30, 2022   120,137,124      
Ending balance at Sep. 30, 2022 $ 25,214,581 $ 120,138 $ 178,307,716 $ (153,080,771) $ (132,502)